Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: A comparison between calcium channel blocker and thiazide-based regimens

American Journal of Hypertension

Volumn 11, Issue 3 I, 1998, Pages 263-271

  Sihm, Inger ^a,d   Schroeder, Anne Pauline ^b   Aalkjær, Christian ^c   Mulvany, Michael J ^c   Thygesen, Kristian ^a   Lederballe, Ole ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d NONE   (Denmark)

Author keywords

Heart; Hypertension; Treatment; Vessel

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; HYDRALAZINE; ISRADIPINE; NITRENDIPINE; PINACIDIL; URAPIDIL;

ADULT; ARTERY MEDIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SCREENING; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GLUTEUS MAXIMUS MUSCLE; HEART LEFT VENTRICLE MASS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE BLOOD VESSEL;

ADULT; AMILORIDE; ANTIHYPERTENSIVE AGENTS; ARTERIES; BUTTOCKS; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; ISRADIPINE; MALE; MIDDLE AGED; MYOCARDIUM; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0031955583     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00475-5     Document Type: Article

References (43)

1. Folkow B, Grimby G, Thulesius O: Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand 1958;44:255-272.
2. Furuyama M: Histometrical investigations of arteries in reference to arterial hypertension. Tohoku J Exper Med 1962;76:388-414.
3. Aalkjær C, Heagerty AM, Petersen KK, et al: Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987;61:181-186.
4. Sihm I, Schroeder AP, Aalkjær C, et al: The relation between peripheral vascular structure, left ventricular hypertrophy, and ambulatory blood pressure in essential hypertension. Am J Hypertens 1995;8:987-996.
5. Levy D, Garrison RJ, Savage DD, et al: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990;322:1561-1566.
6. Anderson PG, Bishop SP, Digerness SB: Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats. Circ Res 1989;64:1127-1136.
7. Friberg P, Nordlander M: Influence of long-term antihypertensive therapy on cardiac function, coronary flow and myocardial oxygen consumption in spontaneously hypertensive rats. J Hypertens 1986;4:165-173.
8. Trimarco B, De Luca N, Ricciardelli B, et al: Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy. Am J Cardiol 1988;62:745-750.
9. Muiesan ML, Agabiti-Rosei E, Romanelli G, et al: Left ventricular systolic function in relation to withdrawal of different pharmacological treatments in hypertensives with left ventricular hypertrophy. J Hypertens 1988;6(suppl 4):S97-S100.
10. Messerli FH, Nunez BD, Nunez MM, et al. Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrythmias. Arch Intern Med 1989;149:1263-1267.
11. Liebson PR, Savage DD: Echocardiography in hypertension: A review. II. Echocardiographic studies of the effects of antihypertensive agents on left ventricular wall mass and function. Echocardiography 1987;4:215-249.
12. Cruickshank JM, Lewis J, Moore V, Dodd C: Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6: 85-90.
13. Motz W, Vogt M, Scheler S, et al: Coronary circulation in arterial hypertension. J Cardiovasc Pharmacol 1991; 17(suppl 2):S35-S39.
14. Brush JE, Cannon RO, Schenke WH, et al: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-1307.
15. Scheler S, Motz W, Strauer BE: Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol 1994;73:478-482.
16. Agabiti-Rosei E, Muiesan ML, Geri A, et al: Relation between cardiac hypertrophy and forearm vascular structural changes before and during long-term antihypertensive treatment. Am J Med 1988;84(suppl 3A): 125-128.
17. Agabiti-Rosei E, Muiesan ML, Geri A, et al: Long-term antihypertensive treatment may induce normalization of left ventricular mass before complete regression of vascular structural changes: consequences for cardiac function at rest and during stress. J Hypertens 1988; 6(suppl 4):S94-S96.
18. Grossman E, Oren S, Garavaglia GE, et al: Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension. Circulation 1988;78: 1394-1400.
19. Schiffrin EL, Deng LY, Larochelle P: Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23:83-91.
20. Thybo NK, Stephens N, Cooper A, et al: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25:474-481.
21. Sihm I, Schroeder AP, Aalkjær C, et al: Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril. Blood Pressure 1995; 4:241-248.
22. Schiffrin EL, Deng LY, Larochelle P: Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin II-converting enzyme inhibitor. Comparison with effects of a beta-blocker. Am J Hypertens 1995;8:229-236.
23. Schiffrin EL, Deng LY: Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist. J Hypertens 1996;14:1247-1253.
24. Clark S, Fowlie S, Coats A, et al: Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM-2420 according to the AAMI recommendations. J Hum Hypertens 1991;5:77-82.
25. White WB, Pickering TG, Morganroth J, et al: A Multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 1991;4:890-896.
26. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-618.
27. Mulvany MJ, Halpern W: Mechanical properties of vascular smooth muscle cells in situ. Nature 1976;260:617-619.
28. Mulvany MJ, Aalkjær C. Structure and function of small arteries. Physiol Rev 1990;70:921-961.
29. Baumbach GL, Heistad DD: Effects of local reduction in pressure or distensibility and composition of cerebral arterioles. Circ Res 1991;68:338-351.
30. Baumbach GL, Heistad DD: Effects of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats. Circ Res 1983;52:527-533.
31. Dahlöf B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
32. Komsuoglu B, Ozgur O, Duman EL, Komsuoglu SS: The effect of chronic antihypertensive therapy on the index of left ventricular mass in patients with essential hypertension. Int J Cardiol 1989;22:75-81.
33. Franz I-W, Tönnesmann U, Behr U, Ketelhut R: Long-term effect of antihypertensive therapy on left ventricular hypertrophy. J Hypertens 1987;5(suppl 5):S415-S418.
34. Lundin SA, Hallbäk-Nordlander MIL: Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. J Hypertens 1984;2:11-18.
35. Friberg P, Wåhlander H, Nordlander M: Influence of early antihypertensive treatment on vascular and cardiac design in SHR with and without renal hypertension. Blood Pressure 1992;1:172-180.
36. Kleine P, Meissner E, Bruchhauser VV, Bruckner S: Effects of clonidine and nifedipine on left ventricular hypertrophy and muscle mass in hypertensive patients. J Cardiovasc Pharmacol 1987;10(suppl 12): S180-S186.
37. Dahlöf B, Hansson L: The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide. J Int Med 1993;234:271-279.
38. Svensson A, Gudbrandsson T, Sivertsson R, Hansson L: Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients. Br J Clin Pharmacol 1982;13:259s-267s.
39. Gretzer I, Duner H, Lagerbæck B: Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation. J Hypertens 1985;3(suppl 3): S215-S217.
40. Hartford M, Wendelhag I, Berglund G, et al: Cardiovascular and renal effects of long-term antihypertensive treatment. JAMA 1988;259:2553-2557.
41. Aalkjær C, Eiskjær H, Mulvany MJ, et al: Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens 1989;7: 305-310.
42. Heagerty AM, Bund SJ, Aalkjær C: Effects of drug treatment on human resistance arteriole morphology in essential hypertension: direct evidence for structural remodelling of resistance vessels. Lancet 1988;26:1209-1212.
43. Franz IW, Tönnesmann U, Behr U, Ketelhut R: Rückbildung der Linksherzhypertrophie bei Hochdruckkranken durch antihypertensive Langzeittherapie (in German). Dtsch Med Wschr 1990;115:603-609.